Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study
about
The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's DiseaseThe role of tau in neurodegenerative diseases and its potential as a therapeutic targetLinking the genetic architecture of cytosine modifications with human complex traitsGenetic susceptibility in Parkinson's diseaseGenomewide association study for susceptibility genes contributing to familial Parkinson diseaseRole of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.Physiological transgene regulation and functional complementation of a neurological disease gene deficiency in neuronsMutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease.DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitroPOLG1 polyglutamine tract variants associated with Parkinson's disease.Genome-wide association study confirms extant PD risk loci among the Dutch.Variation in MAPT is not a contributing factor to the incomplete penetrance in LHON.Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals.Tau splicing and the intricacies of dementia.Regulation of human MAPT gene expression.SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian populationIntegration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain.Human inversions and their functional consequencesStructural diversity and African origin of the 17q21.31 inversion polymorphism.Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.Commonalities in the genetics of Alzheimer's disease and Parkinson's disease.Association of the MAPT locus with Parkinson's disease.Back to the tubule: microtubule dynamics in Parkinson's disease.Development of Parkinson's disease biomarkers.A tangled web - tau and sporadic Parkinson's diseaseFUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD.The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.Identification of Parkinson's disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson's disease patients.Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.Secondary RNA structure and nucleotide specificity contribute to internal initiation mediated by the human tau 5' leader.Genetic Architecture of MAPT Gene Region in Parkinson Disease Subtypes.Tau as a biomarker of neurodegenerative diseases.Fractalkine signaling and Tau hyper-phosphorylation are associated with autophagic alterations in lentiviral Tau and Aβ1-42 gene transfer models.MAPT Genetic Variation and Neuronal Maturity Alter Isoform Expression Affecting Axonal Transport in iPSC-Derived Dopamine Neurons.Loss of fused in sarcoma (FUS) promotes pathological Tau splicing.Roles of the tau gene short tandem repeats in late-onset Alzheimer's disease.Association of rs62063857 variant of the saitohin gene with Parkinson's disease.Atypical tauopathy in a patient with LRRK2-G2019S mutation and tremor-dominant Parkinsonism.
P2860
Q26744716-57001565-E2F5-4873-BD55-D30745DFFE45Q27005032-1B3F538B-16AE-4A09-AB08-988B913104DFQ27301341-B292B280-8949-4BA9-961B-FF705C57AEE5Q30435626-79470728-1A7A-4D0A-B89D-BC6E660D128FQ30437480-C03D2787-F838-4060-A02D-FE4E3668CE7DQ33475213-1877EA93-98D0-433C-BED6-33BA37696BF5Q33713988-5B8B0455-BB3F-4DA7-ABFD-8068997B8637Q33754793-30961E5C-3436-4F00-921B-F8B9317D47D4Q33818001-8C27DD29-B7BA-4919-B9D4-E0A45C3FF54EQ34002331-5B7078EF-8B76-4545-B814-374ED3D4BF8FQ35030975-C7CAA835-A1CE-451D-B00D-4BFE03AFD42DQ35045343-99C282A8-8D1C-44CE-B611-42CF1D87E4C1Q35158915-E840BACD-6C3D-4C27-BBD5-8476EB2692B9Q35226142-BE376496-BE9C-44F2-BA21-6A3CBA49F0A2Q35844758-3A0C30EE-DD15-4ABA-BE01-ADEDAA21D5F2Q35859538-F946860A-01CC-44DE-865D-D61975C25601Q35980870-FF8183FA-7075-4391-BE22-2486026F20A7Q36077972-B9274209-7846-45A4-AC03-F410A3703333Q36129488-AB663960-8648-41C4-B6D2-DB9ABB469572Q37006170-D41731DA-555C-4C13-9A0B-8C074EFF9313Q37312762-C1E1D520-7A6D-4223-A10B-8DA83BF12B81Q37352061-668717FA-77CF-4DA9-B98D-407C747CF483Q37531274-4C93D0F1-F978-445F-845A-E83356D41866Q37590635-26422A38-ECC2-46E4-84AA-35D399EE941EQ37810992-3025D752-CF2E-4C7A-A4CF-EB940A38C8F4Q37855547-FF3AB861-B50A-47CB-AD0A-468DCB8917CEQ38131381-D1B43558-89B8-4DF6-A8DF-B87497B6CA15Q38378476-73CC9CC7-AFE2-4C71-82D4-890C9AC3F246Q38503340-6E769525-0859-40F7-9C4E-9AD0E26CEBAEQ38738200-E9F28AFF-EF85-4C30-A075-5DFB62B062B0Q39237805-161CAEE6-149B-4A0F-8C5D-E4A9E15BEEB9Q39274764-AC534E5C-FD5F-46E8-9036-AF2D21A80A85Q40012093-0516BA67-5C74-403D-96E9-BAE10A4A7568Q40065021-CCBD19E2-2B46-4F0E-A4FB-AE6D04DA95E4Q40392115-F0B018EA-E7E8-4781-A59B-560750FD3A53Q41325226-CBF0A8CF-C459-4B9B-8B4C-CCE66B951F9AQ42138048-E5AA93E8-0BCE-4677-8788-144C5957D7BAQ45723091-C4D5C44C-AD2A-4890-93EC-1051D08E4D2AQ46066849-7DB09062-C145-446D-AB54-2021B0354B6CQ50262835-43E28BE6-9891-4AEB-9A1A-88E67E99FA18
P2860
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Haplotypes and gene expression ...... nson disease: the GenePD Study
@ast
Haplotypes and gene expression ...... nson disease: the GenePD Study
@en
type
label
Haplotypes and gene expression ...... nson disease: the GenePD Study
@ast
Haplotypes and gene expression ...... nson disease: the GenePD Study
@en
prefLabel
Haplotypes and gene expression ...... nson disease: the GenePD Study
@ast
Haplotypes and gene expression ...... nson disease: the GenePD Study
@en
P2860
P50
P1433
P1476
Haplotypes and gene expression ...... nson disease: the GenePD Study
@en
P2860
P356
10.1212/01.WNL.0000304051.01650.23
P4011
b27137b208a5ace546a2672c322d75781909d404
P407
P50
P577
2008-05-28T00:00:00Z